Allon Therapeutics, Inc. reported earnings results for the year ended December 31, 2012. For the year, the company reported a net loss of $14,916,297 or $0.12 per share compared to a net loss of $12,774,995 or $0.15 per share for the year ended December 31, 2011, representing an increase in net loss of $2,141,302.